XML 36 R43.htm IDEA: XBRL DOCUMENT v2.4.1.9

INTANGIBLE ASSETS (Details ) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Finite-Lived Intangible Assets
Accumulated Amortization	$ (113,640)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization	$ (90,160)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
Indefinite-Lived Intangible Assets
Gross Carrying Amount	1,342,228us-gaap_IntangibleAssetsGrossExcludingGoodwill	755,748us-gaap_IntangibleAssetsGrossExcludingGoodwill
Net Amount	1,228,588us-gaap_IntangibleAssetsNetExcludingGoodwill	665,588us-gaap_IntangibleAssetsNetExcludingGoodwill
Hormone therapy drug candidate patents - Pending [Member]
Indefinite-Lived Intangible Assets
Gross Carrying Amount	675,982us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill / us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis = txmd_HormoneTherapyDrugCandidatePatentsMember	572,726us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill / us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis = txmd_HormoneTherapyDrugCandidatePatentsMember
Net Amount	675,982txmd_IndefiniteLivedIntangibleAssetsExcludingGoodwillNet / us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis = txmd_HormoneTherapyDrugCandidatePatentsMember	572,726txmd_IndefiniteLivedIntangibleAssetsExcludingGoodwillNet / us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis = txmd_HormoneTherapyDrugCandidatePatentsMember
Multiple trademarks for vitamins/supplements [Member]
Indefinite-Lived Intangible Assets
Gross Carrying Amount	103,368us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill / us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis = txmd_MultipleTrademarksForVitaminsSupplementsMember	59,328us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill / us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis = txmd_MultipleTrademarksForVitaminsSupplementsMember
Net Amount	103,368txmd_IndefiniteLivedIntangibleAssetsExcludingGoodwillNet / us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis = txmd_MultipleTrademarksForVitaminsSupplementsMember	59,328txmd_IndefiniteLivedIntangibleAssetsExcludingGoodwillNet / us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis = txmd_MultipleTrademarksForVitaminsSupplementsMember
OPERA software patent [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	31,951us-gaap_FiniteLivedIntangibleAssetsGross / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = us-gaap_ComputerSoftwareIntangibleAssetMember	31,951us-gaap_FiniteLivedIntangibleAssetsGross / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = us-gaap_ComputerSoftwareIntangibleAssetMember
Accumulated Amortization	(2,496)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = us-gaap_ComputerSoftwareIntangibleAssetMember	(499)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = us-gaap_ComputerSoftwareIntangibleAssetMember
Net Amount	29,455us-gaap_FiniteLivedIntangibleAssetsNet / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = us-gaap_ComputerSoftwareIntangibleAssetMember	31,452us-gaap_FiniteLivedIntangibleAssetsNet / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = us-gaap_ComputerSoftwareIntangibleAssetMember
Weighted Average Amortization Period	14 years 9 months	15 years 9 months 18 days
Development costs for corporate website [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	91,743us-gaap_FiniteLivedIntangibleAssetsGross / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = us-gaap_InternetDomainNamesMember	91,743us-gaap_FiniteLivedIntangibleAssetsGross / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = us-gaap_InternetDomainNamesMember
Accumulated Amortization	(91,743)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = us-gaap_InternetDomainNamesMember	(89,661)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = us-gaap_InternetDomainNamesMember
Net Amount		2,082us-gaap_FiniteLivedIntangibleAssetsNet / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = us-gaap_InternetDomainNamesMember
Weighted Average Amortization Period		3 months 18 days
Approved Hormone Therapy Drug Candidate Patents (Member)
Finite-Lived Intangible Assets
Gross Carrying Amount	439,184us-gaap_FiniteLivedIntangibleAssetsGross / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = txmd_ApprovedHormoneTherapyDrugCandidatePatentsMember
Accumulated Amortization	(19,401)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = txmd_ApprovedHormoneTherapyDrugCandidatePatentsMember
Net Amount	$ 419,783us-gaap_FiniteLivedIntangibleAssetsNet / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = txmd_ApprovedHormoneTherapyDrugCandidatePatentsMember
Weighted Average Amortization Period	18 years

X

- Definition

Net amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.

+ References

No definition available.

+ Details

Name:	txmd_IndefiniteLivedIntangibleAssetsExcludingGoodwillNet
Namespace Prefix:	txmd_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (a)(3)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275

+ Details

Name:	us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name:	us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name:	us-gaap_FiniteLivedIntangibleAssetsGross
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name:	us-gaap_FiniteLivedIntangibleAssetsNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsNetAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name:	us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Details

Name:	us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount before accumulated amortization of intangible assets, excluding goodwill.

+ References

No definition available.

+ Details

Name:	us-gaap_IntangibleAssetsGrossExcludingGoodwill
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274



Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph ((a)(1),(b))

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name:	us-gaap_IntangibleAssetsNetExcludingGoodwill
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=txmd_ApprovedHormoneTherapyDrugCandidatePatentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InternetDomainNamesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=txmd_HormoneTherapyDrugCandidatePatentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=txmd_MultipleTrademarksForVitaminsSupplementsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: